Glenmark Pharma shares hit upper circuit limit after signing a USD 2 billion deal with AbbVie for a cancer drug. Stock hits ...

After Glenmark’s landmark $2 billion licensing deal with US major AbbVie for its cancer drug, ISB 2001, the stock hit the 10% ...

The licensing deal is the largest one by any Indian pharma company, and the deal value is above expectations, said Nomura.

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corp. (NVDA), Walmart Inc.

Strategists at JPMorgan say retail investors will help drive stock gains this year, and foreign investors could pitch in.

That cohort is going to keep driving the market higher, says our call of the day from JPMorgan, which predicts that retail investors will lead a $500 billion wall of money flowing into U.S. stocks in ...